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Bacillus cereus is an important cause of foodborne infectious disease and food
poisoning. However, B. cereus has also been used as a probiotic in human medicine
and livestock production, with low standards of safety assessment. In this study, we
evaluated the safety of 15 commercial probiotic B. cereus preparations from China in
terms of mislabeling, toxin production, and transferable antimicrobial resistance. Most
preparations were incorrectly labeled, as they contained additional bacterial species;
one product did not contain viable B. cereus at all. In total, 18 B. cereus group
strains—specifically B. cereus and Bacillus thuringiensis—were isolated. Enterotoxin
genes nhe, hbl, and cytK1, as well as the ces-gene were assessed by PCR.
Enterotoxin production and cytotoxicity were confirmed by ELISA and cell culture
assays, respectively. All isolated B. cereus group strains produced the enterotoxin
Nhe; 15 strains additionally produced Hbl. Antimicrobial resistance was assessed by
microdilution; resistance genes were detected by PCR and further characterized by
sequencing, transformation and conjugation assays. Nearly half of the strains harbored
the antimicrobial resistance gene tet(45). In one strain, tet(45) was situated on a
mobile genetic element—encoding a site-specific recombination mechanism—and was
transferable to Staphylococcus aureus and Bacillus subtilis by electro-transformation. In
view of the wide and uncontrolled use of these products, stricter regulations for safety
assessment, including determination of virulence factors and transferable antimicrobial
resistance genes, are urgently needed.
Keywords: Bacillus cereus, probiotic, enterotoxin, antimicrobial resistance, China, tetracycline resistance gene
tet(45), site-specific recombination, dif site
INTRODUCTION
Bacillus cereus is a common cause of foodborne infectious disease: in a 10-year US survey B. cereus
was ranked the fifth most common bacterial species causing foodborne outbreaks (http://www.cdc.
gov/foodsafety/pdfs/fdoss-98-08-appendix-contributing-factors-508c.pdf; for detailed outbreak
analysis see Bennett et al., 2013). Worldwide, Chinese food is frequently associated with foodborne
B. cereus outbreaks (Notermans and Batt, 1998). Accordingly, B. cereus accounted for 13.4%
of 1082 bacterial foodborne outbreaks between 1994 and 2005 in China; B. cereus was ranked
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as the second after Salmonella spp. amongst the most frequent
bacterial causes of foodborne disease in Chinese inland provinces
(Wang et al., 2007). This might be partly attributed to
consumption habits, since B. cereus outbreaks are regularly
associated with the consumption of rice (Ankolekar et al., 2009).
In addition to rice (and pasta), meat, and dairy products are
also important sources of foodborne B. cereus outbreaks in
humans (Ruusunen et al., 2013; López et al., 2015). There are
two different types of foodborne disease related to B. cereus:
intoxication due to pre-formed cereulide or infection, followed
by intra-intestinal production of enterotoxins such as Nhe and
Hbl (Stenfors Arnesen et al., 2008). Foodborne B. cereus disease
is generally self-limiting, although severe cases and even deaths
have been reported (Bottone, 2010).
Though, being known as an important foodborne pathogen,
B. cereus is licensed as a probiotic for men and livestock.
In China, the safety of B. cereus probiotics is assessed and
regulated; however, these regulations are partly rendered obsolete
by recent research on B. cereus, particularly the identification
of new virulence factors (Kim et al., 2015; Omer et al., 2015;
Kilcullen et al., 2016). Thus, there is a lack of appropriate safety
assessment for these probiotics in China—and also in other
parts of the world—although, probiotics are even used to treat
bacterial infections (Isolauri, 2003). In legal terms, probiotics
are usually considered as supplements or foods—a fact which
is critically discussed (Arnold, 2013). Apart from one pseudo-
outbreak (Kniehl et al., 2003), no case of foodborne B. cereus
infection due to the use of probiotics has theretofore been
reported. However, a fatal infection following the application
of a probiotic Bacillus subtilis preparation was reported in an
immune-compromised patient (Oggioni et al., 1998).
Probiotic strains are applied to livestock as well. Thus, the use
of B. cereus probiotics in livestock production might provide an
additional hazard for human health. In China, animal wastes are
traditionally used as feed in fish ponds; this creates a melting
pot for bacteria of human, animal, and environmental origin and
thereby facilitates horizontal gene transfer (Allen et al., 2010).
Thus, besides the lack of detectable toxicity, future probiotic
safety regulations should take into account the potential of
transferring antibiotic resistance genes.
We hypothesize that toxin production, transferable
antimicrobial resistance, and contamination with other bacteria
are important safety aspects of probiotics, but insufficiently
assessed up to now. Therefore, we intended to re-evaluate these
important safety parameters in commercial probiotic B. cereus
products.
MATERIALS AND METHODS
Isolation and Identification of Bacteria
Products were collected between 2013 and 2015 from nine
provinces in China (Table 1). This investigation included all four
B. cereus preparations licensed for human use. From the original
packaging, the capsules with the dried probiotic preparations
were removed with a tweezer, dipped into 80% ethanol, flame-
treated and soaked in sterile distilled water until the capsules
where dissolved. Subsequently, the content was suspended and
0.1ml of the suspension was plated on Columbia agar with
5% sheep blood (Oxoid, Wesel, Germany). Single colonies of
each different phenotype were passaged on new agar plates.
Matrix assisted laser desorption/ionization (MALDI-TOF) mass
spectrometry was used for bacterial identification (Schulthess
et al., 2014). Phenotypic identification by means of biochemical
tests with the API 50 CH and 20 E kits (BioMerieux) were
used to further confirm and/or characterize the B. cereus group
bacteria. The total DNA of each isolate was extracted from
overnight cultures in casein hydrolysate-yeast medium plus 1%
glucose (CGY) using the DNeasy blood and tissue kit (Qiagen,
Germany), according to the protocol for Gram-positive bacteria.
An extended multiplex PCR assay with five pairs of universal
primers was used to identify the cry-group genes in the Bacillus
thuringiensis strains (Ben-Dov et al., 1997).
Detection of Enterotoxins and Emetic Toxin
The four main toxin genes of B. cereus, ces, nhe, hbl, and
cytK1, were detected as previously described (Wehrle et al.,
2009). Enzyme-linked immunosorbent assays were used to
detect the production of B. cereus toxins, based on monoclonal
antibodies specifically recognizing different epitopes of each
toxin component (Zhu K. et al., 2013). Cytotoxicity assays
were performed on Vero and HEp-2 cells to evaluate the toxic
potential of the strains due to the production of enterotoxins
(Nhe, Hbl, and CytK1) and/or emetic toxin (cereulide),
respectively (Wehrle et al., 2009). B. cereus NVH 75/95,
DSMZ 4384, andMHI 165 were used as reference strains for Nhe,
Hbl, and cereulide, respectively (Wehrle et al., 2009; Lindbäck
et al., 2010). B. cereus NVH 391/98 served as reference strain
for CytK1, with a variant nhe-gene and no expression of the Nhe
complex in the bacterial culture medium (Fagerlund et al., 2007).
Assessment of Phenotypic Antimicrobial
Resistance
Antimicrobial resistance was assessed by a standardized
microdilution assay (ISO 20776-1:2006) in cation adjusted
Mueller Hinton broth (CAMHB). The assay included ampicillin,
amoxicillin + clavulanate, cefaclor, cefoxitin, cefuroxime,
ciprofloxacin, clindamycin, colistin, daptomycin, doxycycline,
enrofloxacin, ertapenem, erythromycin, florfenicol, fosfomycin,
gentamicin, imipenem, linezolid, meropenem, oxacillin,
penicillin, quinupristin + dalfopristin, rifampicin, streptomycin,
teicoplanin, telithromycin, tobramycin, and vancomycin.
Detection of Antimicrobial Resistance
Genes
The presence of the tetracycline resistance genes tet(A), tet(B),
tet(C), tet(D), tet(K), tet(L)/tet(45), tet(M), and tet(O) was
assessed by end-point PCR as described elsewhere (Smith
et al., 2004; Srinivasan et al., 2008; You et al., 2012); this
selection included the most commonly detected tet-genes in
Bacillus cereus (Agersø et al., 2002), but also four genes—
tet(A), tet(B), tet(C), tet(D)—that were not yet found in the
genus Bacillus (http://faculty.washington.edu/marilynr/tetweb3.
pdf). PCR products were purified and submitted for sequencing
(Sequiserve, Vaterstetten, Germany). The obtained sequences
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TABLE 1 | Characterization of commercial B. cereus containing probiotic products in China.
Product No. Strain No. Origin Label Other species Intended for use in Species Toxin type
1 1 Jiangsu mono none Human B. cereus Nhe, Hbl
2 2a Jiangsu mono none# B. cereus Nhe, Hbl
2b B. cereus Nhe
3 3 Henan mono none B. cereus Nhe, Hbl
4. 4 Zhejiang mixed not determined B. cereus Nhe, Hbl
5 5c Jiangsu mono other Bacillus spp. Animal B. cereus Nhe
6 6f Hebei mono other Bacillus spp.
Acinetobacter sp.
Enterococcus sp.
no ID.
B. cereus Nhe, Hbl
7 7d Hebei mono other Bacillus spp. B. thuringiensis Nhe, Hbl, Cry
8 8h Hebei mixed other Bacillus spp. B. cereus Nhe, Hbl
9 9b Hebei mixed other Bacillus spp.
Staphylococcus
sp.
Pseudomonas sp.
B. thuringiensis Nhe, Hbl, Cry
9i B. cereus Nhe
10 Hebei mixed other Bacillus spp.
Enterococcus sp.
Cronobacter sp.
Acinetobacter sp.
none
11 11 Shandong mono none B. cereus Nhe, Hbl
12 12c Jiangxi mixed other Bacillus spp. B. cereus Nhe, Hbl
13 13d Guangdong mono other Bacillus spp. B. cereus Nhe, Hbl
14 14e Shanxi mixed other Bacillus spp. Plant B. cereus Nhe, Hbl
14f B. thuringiensis Nhe, Hbl, Cry
15 15a Hubei mixed other Bacillus spp. B. thuringiensis Nhe, Hbl, Cry
15d B. cereus Nhe, Hbl
“Toxin type” refers to the detection of the corresponding gene in the PCR-assay plus positive ELISA-reaction at the level of the reference strains plus cytotoxicity for Vero-cells.
# two different B. cereus strains.
were compared with public databases (NCBI, EMBL-EBI) to
verify the PCR products and to distinguish between tet(L) and
tet(45) (You et al., 2013).
Transferability of Antimicrobial Resistance
Transformation Assay
Electro-transformation
The spread of antimicrobial resistance genes was determined in
a modified transferability test as described elsewhere (Zhu W.
et al., 2013). Plasmids of the B. cereus strain 9i were extracted
by QIAfilter Plasmid Midi Kit (QIAGEN R©). Subsequently,
500 ng of the purified plasmids were transformed into
Staphylococcus aureus RN4220 electrocompetent cells, at
200 , 25µ Fd, 2500V. After incubation at 37◦C for 2 h, the
resulting transformants were spread on brain heart infusion
(BHI) agar plates containing 16 mg/L tetracycline, and incubated
at 37◦C for another 24 to 48 h. Isolated single colonies were
tested for the presences of tet(45) by PCR assay, and the
obtained PCR products were submitted for sequence analysis.
Electro-transformation of B. subtilis ATCC 6051, Escherichia
faecalis JH2-2, Bacillus licheniformis ATCC 14580 and Bacillus
amyloliquefaciens ATCC 23842 followed the same protocol.
Chemical transformation
For the preparation of competent cells of B. subtilis ATCC
6051, B. subtilis was cultured on LB agar plates at 37◦C for
24 h; a single colony was inoculated in 5mL GM1 medium
and shaken at 100 rpm (37◦C) for 16 h. Subsequently, 2mL
of B. subtilis culture was transferred to 18mL GM1 medium
and shaken at 100 rpm (37◦C) for another 3 h. Ten milliliters
of the culture was subsequently transferred into 90mL GM2
medium and shaken at 100 rpm (37◦C) for 2 h. Lastly, all the cells
were collected after centrifugation at 4000 rpm (4◦C) for 10min
and re-suspended by 10mL GM2 medium with the addition of
5mL 30% glycerol to prepare the competent cells of B. subtilis.
Chemical transformation was performed with Escherichia coli
(DH5α) and B. subtilis competent cells as recipients using
0.5–1µg plasmid DNA extracted from the donor strain B. cereus
9i, according to the manufacturer’s instruction (TaKaRa).
Conjugation Assay
Filter matings were performed with E. coli (EC600, rifampin
resistant), S. aureus (RN4220), E. faecalis (JH2-2, rifampin
resistant), and B. subtilis (ATCC 6051) as the recipient strains,
following the method described elsewhere (Huys et al., 2004).
Overnight cultures of the donor (B. cereus 9i) or recipient strains
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were diluted to 108 CFU/mL in brain heart infusion (BHI) broth
(Land Bridge Technology). Five microliters of each dilution was
added into 1mL BHI broth and incubated at 37◦C for 4 h. The
cultures of donor (20µL) and recipients (60µL) were mixed
and filtered through a sterile 0.2µmmembrane filter (Millipore),
and placed at 37◦C for overnight incubation. After mating, the
colonies were washed with 1mL BHI broth and plated on BHI
agars, containing 8µg/mL TET and further incubated at 37◦C
for 24 h. For the selection of potential transconjugants, the agar
plates contained 8µg TET /mL; for E. coli EC600 and E. faecalis
JH2-2, 25µg rifampin /mL was added. Potential transformants
grown on the selective agar plates were identified by 16S rRNA-
gene sequences and tested for the presences of tet(45) by PCR
assay.
Genetic Environment of tet(45)
The DNA of B. cereus 9i was extracted (Wizard Genomic
DNA Purification Kit, Promega) and partially identified by
high-throughput sequencing (Illumina Hiseq 2500, performed
at BerryGenomics Inc., Beijing China). A preliminary draft
assembly of the genomic fragments was conducted using CLC
Genomics Workbench 5 (CLC Bio, Aarhus, Denmark).
Once the surrounding of tet(45) was known, we designed
primer pairs targeting the upstream- and downstream-
environment of tet(45): UP-tet(45) (fw: TGGTTGAAGAGG
CACTCTATGG, rv: GGCGTAAATTTGACTGTGAATGA),
tet(45)-INT1 (fw: TCATCGTCATTAGCTGGTTGGT, rv: AAG
TTGCAGAGGACATGGAAAAAC), INT1-INT2 (fw: TTT
TCGGGGTTGATGGGCAA, rv: CGATGAGGAAAAACATCG
AGAATCA), INT2-HTH (fw: GCGTGGCTTGTCCTTTCT
AAC, rv: AGAACCCCAACAAGACTCCC), in order to verify
the environment of tet(45) in representatives of each different
variant of tet(45). All PCR-reactions were performed with an
initial denaturation of 5min at 94◦C, 35 cycles of 60 s at 94◦C,
60 s at 54◦C, 90 s at 72◦C, and a final elongation of 5min at 72◦C.
B. cereus 9i served as positive control.
RESULTS
Presence of Multiple Bacterial Species
A total of 66 morphologically different strains were isolated
from 15 typical samples labeled as products containing B. cereus
in mono-preparation (Product No. 1–3, 5–7, 11, and 13) or
mixed preparation (Product No. 4, 8–10, 12, 14, and 15). Based
on bacterial morphology and biochemical testing results, as
well as cry-gene based multiplex-PCR and MALDI-TOF mass
spectrometry, these 66 isolates were classified as belonging to
more than 10 different bacterial species; 18 strains were identified
as belonging to the B. cereus group (Table 1). Four of these strains
were further identified as B. thuringiensis due to the presence of
the plasmid-borne cry-genes encoding insecticidal crystal toxins
(cry1+cry2+cry7/8 in strains 9b, 14f, and 15a; cry2 in strain 7d).
One sample (No. 10) did not contain viable B. cereus, but viable
B. subtilis spores, instead. In total, this product contained nine
different viable bacterial strains, including Cronobacter sakazakii
and Acinetobacter baumannii.
Detection of Toxins
The PCR-assay detected nhe in all isolated B. cereus group strains
(Table 1); hbl was detected in 15 isolates; accordingly, all strains
were cytotoxic for Vero-cells. None of the isolates harbored ces-
genes which are a hallmark of emetic strains, or cytK1. Enzyme-
linked immunosorbent assays confirmed that non-hemolytic
enterotoxin (Nhe) and hemolysin BL (Hbl) were expressed by
the nhe-/hbl-positive strains at the levels of the respective positive
controls.
Antimicrobial Resistance
Microdilution according to ISO-20776 indicated natural
(species-specific) insusceptibility to penicillins (ampicillin,
oxacillin, penicillin), cephalosporins (cefaclor, cefoxitin,
cefuroxime), and colistin, as well as varying susceptibility for
daptomycin, amoxicillin+clavulanate, and fosfomycin (Table 2).
Microdilution further revealed eight isolates (44%) with elevated
MIC-values for doxycycline (1–4mg/L) whereas all other isolates
had MIC-values ≤0.125–0.25mg doxycycline /L. The same eight
strains were positive for tet(45). Sequence analysis revealed that
seven tet(45) amplicons were identical among each other, but the
amplicon of the eighth strain, 9i, showed a different sequence
(Figure 1).
Plasmid Extraction and Horizontal Transfer
Further investigations demonstrated that B. cereus 9i contained
two plasmids, one of ∼10 kB and one of > 50 kB in size
(Figure 2). Both plasmids were assumedly low copy plasmids,
generating reproducible, but weak bands on agarose gel
(Figure 2). The tet(45)-gene of 9i was successfully transferred
into S. aureus RN4220 and B. subtilis ATCC6051 (but not E. coli)
by electro-transformation. Transformed S. aureus and B. subtilis
increased their doxycycline MIC-values from ≤0.25 to 2 mg/L.
After electro-transformation, the tet(45)-gene was amplified
in the DNA-extracts of the putative transformants. However,
neither chemical transformation nor conjugation assays resulted
in detectable transfer of tet(45).
Genetic Environment of tet(45)
Partial sequence analysis of the DNA extracts is visualized
in Figure 3. The tet(45)-gene is located on a putatively
mobile genetic element (MGE) of 6789 bp (Genbank accession
number KX091844). Upstream, the MGE starts with a dif SL-
like binding motif (Figure 3) situated on a 413 bp sequence
of unknown function, which precedes tet(45). Downstream,
tet(45) is followed by a gene encoding a protein of unknown
function. The insertion element further contains two different
integrase genes (2181/1347 bp)—at least one of the integrases
with significant similarity to a site-specific tyrosine recombinase,
XerS—and a 552 bp gene encoding a MerR superfamily protein
(putative excisionase) with a helix-turn-helix domain.
With DNA-extracts of two representatives of the second
tet(45)-variant, no amplicons were generated when we used
primer pairs UP-tet(45), tet(45)-INT1, INT1-INT2, or INT2-
HTH, while amplicons of the expected size were found for
B. cereus 9i (positive control) in each PCR-reaction.
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FIGURE 1 | Partial amino acid sequence of Tet(45). Amino acid sequence alignment of tet(45)-amplicons (a, strain No. 6f, 7d, 8h, 11, 13d, 14e and 15d) and the
mobile genetic element- tet(45)-amplicon (b, strain No. 9i) with Tet(45) from Bhargavaea spp. (Ref, You et al., 2013; blastx, https://npsa-prabi.ibcp.fr).
Sequences of the mobile genetic element and of the second
tet(45) variant (partial sequence) were deposited in Genbank
(accession numbers KX091844 and KX091845).
DISCUSSION
Mislabeled Probiotic Products
Five products labeled as B. cereus-monopreparations contained
bacterial species which did not belong to the B. cereus group.
Mislabeling of probiotic Bacillus strains is a common problem
also observed in Europe, where Bactisubtil has been firstly labeled
to contain B. subtilis spores instead of B. cereus spores (Huys
et al., 2013). Vice versa, in our study one preparation for use in
livestock did not contain any viable B. cereus group strain, but
B. subtilis spores, instead. In addition, the product contained two
opportunistic human pathogens, A. baumannii and C. sakazakii;
the latter outnumbered the B. subtilis spores (data not shown).
Toxins
Due to the presence of plasmid-borne cry-group-genes, which
encode insecticidal toxins, four strains were identified as
B. thuringiensis. Two of them were isolated from preparations
that were not labeled to contain B. thuringiensis. B. cereus is
closely related to B. thuringiensis: the 16S rRNA-gene sequences
share more than 99% similarity (Stenfors Arnesen et al., 2008).
The insecticidal toxins of B. thuringinesis are not harmful for
mammals; however, the isolates also produced enterotoxins (Hbl
and Nhe), as did all of the B. cereus group strains (Table 1).
Hbl and Nhe are pore-forming toxins, each composed of three
individual proteins, which show a specific order of binding to
mammalian cells. Although the mode of action of these toxins
is not fully understood, assembly of the components seems to
occur partly in solution and is completed on the cell surface
resulting in pore formation and cell lysis (Lindbäck et al., 2010;
Sastalla et al., 2013). For both toxins, the presence of all three
compounds is necessary to evoke toxicity, and only strains
expressing complete Hbl and/or Nhe can be regarded as diarrheic
(Stenfors Arnesen et al., 2008). This was the case for all isolated
B. cereus group strains, the expression level of Nhe was even
similar to the reference strain isolated from a food poisoning
case in Norway (Lund and Granum, 1996; data not shown).
A probiotic B. cereus strain licensed in the European Union
has also been shown to produce biologically active enterotoxins
(Nhe, Hbl; Duc et al., 2004). Interestingly, a preparation of this
strain was withdrawn for use in animals, while still included in a
licensed—but originally mislabeled—preparation for human use
(Huys et al., 2013; Hong and Cutting, 2005).
Enteropathogenic B. cereus
The infectious dose of enteropathogenic B. cereus was proposed
to be 1 × 105 to 1 × 108 CFU or spores/g (Granum and
Lund, 1997). Variations in this infectious dose are attributed to
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FIGURE 2 | Agarose gel electrophoresis after plasmid extraction of B.
cereus 9i. 1–3: three independent replicates. S supercoiled ladder, L linear
ladder. Note: two putative plasmid bands were visible in a second agarose gel
electrophoresis of extract 9i-3, at the same height as in extract 9i-1.
strain traits, since strains differ both in the amount of toxins
produced (Dommel et al., 2011; Jessberger et al., 2015; Lücking
et al., 2015), and also in their capability for intestinal persistence.
Probiotic strains are applied in a dose of 107–109CFU or spores/g;
they have also been selected for their ability to colonize the
intestinal tract (Duc et al., 2004). Thus, given their high likelihood
to establish colonies in the intestine, unsafe probiotic strains
might provide a major health risk, compared to strains casually
ingested with food. Such health risks have been demonstrated
in case studies. For example, a fatal infection with a probiotic
Bacillus preparation in an immune-compromised patient has
been reported (Oggioni et al., 1998).
Transferable Antimicrobial Resistance
Gene
Besides the lack of toxicity, the presence of transferable resistance
genes or not is another major safety parameter for probiotic
strains. At least one of the strains investigated in the current study
carried a tetracycline resistance gene, tet(45), on a mobile genetic
element. In Bacillus spp., some corresponding entries in Genbank
are labeled as “tetracycline resistance MFS eﬄux pump,” which
overcomes the problem that the protein encoded by tet(45) in
Bacillus spp. is similar to the product of tet(L) so that partial
sequences might not allow unambiguous distinction. However,
the complete sequence presented here has higher similarity to the
reference sequences of tet(45) than to the reference sequences of
tet(L) (http://faculty.washington.edu/marilynr/tetweb4.pdf).
The mobile element contained a dif SL-like binding site,
the tet(45)-gene, one ORF encoding a hypothetical protein,
two integrase genes (one of the XerS superfamily, but
without significant similarity to the XerS-encoding gene of
Streptococcus suis), two non-coding-sequences of unknown
function and a gene encoding a MerC-superfamily protein
(putative excisionase). The coherent mobile element as found
here was not described in Bacillus spp. before, but NCBI-
BLAST revealed 93% identity to an inverse sequence of
B. cereus MSX-D12 (pos. 2856985–2851281), isolated 2005 in
the Antarctic Concordia Station by Timmery et al. (2011). At
5′, the putative MGE in 9i begins with an adenin-rich-motif
(caaaaaagaatcc). This motif was identified as the “left-hand” part
of a putative Xer-binding/cleavage site, since the 3′ (“right-half ”)-
site (tattaaaaggacag) downstream the motif had remarkably high
identity to dif SL (Leroux et al., 2011; bold= consensus), whereas
the sequence had much lower similarity to known Xer-binding
sites of Bacillus spp. (e.g., cer, dif, difBS). MSX-D12 presented a
complementary dif SL-like sequence at 3′ (Figure 3).
The sequence situated upstream of the putative MGE in
9i contains one single caaaaaagaatcctg-cag-motif; an inverted
repeat of the motif, gattcttttttg (missing the cag-sequence
which is adhered at the 5′ cleavage site), follows immediately
downstream of the 3′ end of the MGE. In MSX-D12, the same—
but undisrupted—sequence is situated ∼2,100,000 bp upstream
of the putative mobile element described here, forming a perfect
30 bp palindrome (caaaaaagaatcctg‖caggattcttttttg).
Interestingly, the both opposed ends of the palindrome are
identical to the opposed ends of the “left-hand”-part of dif SL
(Leroux et al., 2011).
Identical upstream and downstream genes—encoding a YdcF-
like protein and an S-layer protein—are found in MSX-D12
(not shown), NC7401 and 9i (Figure 3, respectively) next to
both ends of the palindromic cleavage site. This raises strong
suspicion that, in 9i, tet(45) was inserted into this sequence
by help of (and together with) the site-specific recombinases
encoded downstream. In MSX-D12, the MGE was inserted at
another palindromic site (Figure 3), was inversely orientated,
and its insertion was accompanied by a crossover-event so that
the palindromic sequence at both ends of the MGE was directly
mirrored (tatttttctttttttcttag‖gattcttttttctttttat) instead of being
complimentary.
Remarkably, while the binding site had high homology with
the dif SL-site identified in Streptococcus and Lactococcus, the
XerS-like protein had no significant similarity with the XerS-
proteins of Streptococcus or Lactococcus, and two different
integrase genes were combined in the MGE, hinting toward a
XerC/XerD-like dimeric process of site-specific recombination
instead of a “stand-alone” mechanism as proposed for XerS
(Leroux et al., 2011).
B. cereus 9i contained two plasmids. However, in the
plasmid extracts we could neither identify any gene associated
with conjugation, nor did we succeed in transferring tet(45)
by means of conjugation assays. The YdcF-like-protein and
the S-layer-protein which are connected by the putative insertion
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FIGURE 3 | Genetic environment of tet(45) in B. cereus 9i. Surrounding sequences of tet(45) in B. cereus 9i (this study) and B. cereus MSX-D12 (Timmery et al.,
2011) are shown relatively to B. cereus NC7401 (AP007209.1). Note: most Genbank entries for Bacillus cereus show the same 5’-3’-orientation of the YdcF-like-/
S-layer protein encoding sequences and the Pas domain S-box-/Cof-like protein encoding sequences as 9i and MSX-D12, respectively, not as NC7401. NC7401 was
chosen as reference sequence since the palindromic sequence between the Pas domain S-box-/Cof-like protein encoding sequences is conserved here, but not in
the Bacillus cereus reference genomes.
site are chromosomally encoded in Bacillus spp. This does
not necessarily mean that tet(45) is chromosomally integrated
in 9i, since chromosomal genes could also be transferred to
plasmids, as vice versa. Very recently (2016-03-21) there was a
new Genbank entry of a B. thuringiensis plasmid (pBT1850294,
CP014284.1) which encodes a significantly similar pair of
integrase genes (66% nucleotide identity). However, we assume
that the transfer of tet(45) to S. aureus and B. subtilis was
not necessarily associated with its presence on one of the two
plasmids found in 9i, but was associated with a small mobile
genetic element, instead. Such elements could be easily integrated
into naturally competent hosts after natural transformation,
especially if insertion relies on conserved integrases like the
Xer-superfamily (Midonet and Barre, 2014), as indicated here.
The dif SL-like “right-hand”-motif is present in the genome of
a variety of other bacteria, e.g., Lawsonia intracellularis (e.g.,
CP004029.1), Mycoplasma spp. (e.g., CP014346.1), Clostridia
spp. (e.g., CP011803.1), A. baumannii (e.g., CP014528.1),
Staphylococcus spp. (e.g., KT780704), and other Bacillus spp. (e.g.,
CP012600.1). While it is unknown whether these bacteria express
recombinase enzymes that bind there, at least streptococci and
lactococci are known to do so. Moreover, Aneurinibacillus soli
(AP017312.1) and B. mycoides (CP007626.1) encode a pair of
integrases (and also aMerC-superfamily protein) with significant
similarity to the recombinase enzymes described here, suggesting
a further possibility for interspecific and even intergeneric
transfer of the MGE.
The detection of a mobile tet(45)-gene in probiotics is
certainly undesirable. Due to the presence of a tetracycline
resistance gene located on a mobile genetic element, together
with insufficient data on toxicity, the probiotic B. cereus strain
of Esporafeed Plus has been considered unsafe for use as a feed
additive for calves and pigs in Europe in 1999 (http://ec.europa.
eu/food/fs/sc/scan/out39_en.pdf, accessed March 31, 2016);
more recently, Bacillus toyonensis was considered unsafe for use
in chickens, pigs, cattle and rabbits for the same reason (http://
www.efsa.europa.eu/en/efsajournal/pub/3766, accessed May 12,
2016). The tet(45)-gene has been originally detected in an
environmental bacterium, Bhargavaea spp., from which it
was successfully transferred to E. coli (You et al., 2012).
Many antibiotic resistance genes (ARGs) of common human
pathogenic bacteria are assumed to originate from environmental
bacterial communities (Martínez, 2008; Forsberg et al., 2012).
As a spore-forming bacterium and original soil inhabitant,
B. cereus has a distinct ability to persist in and (re-)adapt to
the environment (Carlin et al., 2010). Therefore, it cannot be
ruled out that mobile resistance determinants may be further
transferred to other soil bacteria, but also to other animal or
human pathogens after excretion of such probiotic B. cereus
strains. The detection of tet(M)-carrying B. cereus in soil was
directly related to manure application in the past (Agersø et al.,
2002; Roberts, 2012). In view of the wide and uncontrolled use
of probiotics, strict regulations are urgently needed to decrease
the probability of transfer of ARGs and safety assessment of
these products must include the determination of antimicrobial
resistance profiles.
Here, we summarize the possible health hazards of
commercial probiotic products advertised to contain B. cereus in
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China due to mislabeling, toxin production and the presence of
transferable antimicrobial resistance. The growing presence of
pharmaceutical and biotechnological companies has contributed
to an increase of B. cereus related products, but these products
are often of poor quality and incorrectly designated. It must
be emphasized that the safety of these commercially available
probiotics is not a limited local public health issue in China,
but may also be relevant worldwide due to global trade and
international travel.
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